A Randomized Phase 2 Study of Paclitaxel and Carboplatin with or without Conatumumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer

Paz-Ares Luis, Bálint Beatrix, de Boer Richard H, van Meerbeeck Jan P, Wierzbicki Rafal, De Souza Paul, Galimi Francesco, Haddad Vincent, Sabin Tony, Hei Yong-jiang, Pan Yang, Cottrell Susan, Hsu Cheng-Pang, RamLau Rodryg
2013